THE QUANTUM INFLECTION POINT
Classical computing has hit a wall in molecular simulation. Quantum applications are rewriting the timeline of biomedical discovery.
THE QUANTUM INFLECTION POINT
Classical computing has hit a wall in molecular simulation. Quantum applications are rewriting the timeline of biomedical discovery.
The MIT's Quantum Economic Advantage Calculator is designed to allow users to explore different combinations of algorithmic problems and quantum hardware. Users can freely deviate from known projections and default parameters to derive their own insights as to the general timeline of when certain scenarios may become economically advantageous to run on a quantum machine.
Quantum computing is no longer just an emerging technology. Mckinsey's Quantum Technology Monitor report shows that over 300 global companies are adopting it, fueling a multibillion-dollar market.
Quantum computing has reached a commercial tipping point, driven by rapid investment growth and expanding industry adoption, positioning the technology to unlock trillions in economic value by 2035.
According to Google Quantum development. a useful, error-corrected quantum computer is within reach for humanity that we might be able to accomplish our goal within the decade.
According to IBM Quantum Research, IBM plans to work with the partners and wider ecosystems to build application services into software applications, empowering the widest adoption of quantum computing and roadmap Video of IBM Quantum Roadmap confirms with rollout plan.
CALCULATING THE FUTURE
Where biological complexity meets next-generation computing power.
Bringing a new pharmaceutical drug to market takes over a decade and costs billions due to massive pre-clinical trial inefficiencies.
Quantum computers leverage the laws of quantum mechanics to provide exponential computing power, running highly accurate chemical and effect modeling.
Projected to be an $850 billion annual market by 2050. Enterprises engaging early gain a permanent first-mover advantage.